Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab

  1. Corral de la Fuente, E.
  2. Olmedo García, M.E.
  3. Orejana Martín, I.
  4. Benito Berlinches, A.
  5. Gómez Rueda, A.
  6. Lage Alfranca, Y.
  7. Garrido, P.
Zeitschrift:
Current Problems in Cancer: Case Reports

ISSN: 2666-6219

Datum der Publikation: 2022

Ausgabe: 5

Art: Artikel

DOI: 10.1016/J.CPCCR.2022.100145 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung